Sign up to save your podcasts
Or
Share Low-dose Tricyclic Antidepressants for Irritable Bowel Syndrome: Definitive Evidence of Benefit from ATLANTIS
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Low-dose Tricyclic Antidepressants for Irritable Bowel Syndrome: Definitive Evidence of Benefit from ATLANTIS
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in Primary Care (ATLANTIS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial,” by Ford AC, Wright-Hughes A, Alderson S, et al. Lancet 2023; 402: 1773-85.
View all episodes
By American College of Gastroenterology
4.8
1616 ratings
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in Primary Care (ATLANTIS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial,” by Ford AC, Wright-Hughes A, Alderson S, et al. Lancet 2023; 402: 1773-85.
More shows like Evidence-Based GI: An ACG Publication and Podcast
View all
Gut Podcast
7 Listeners
NEJM This Week
318 Listeners
American Journal of Gastroenterology Author Podcasts
71 Listeners
JAMA Clinical Reviews
499 Listeners
The Curbsiders Internal Medicine Podcast
3,328 Listeners
Core IM | Internal Medicine Podcast
1,111 Listeners
The Peter Attia Drive
8,021 Listeners
Annals On Call Podcast
196 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
348 Listeners
Behind the Case: An ACG Case Reports Journal Podcast
6 Listeners
The Lancet Gastroenterology & Hepatology in conversation with
0 Listeners
Listen In: GI Endoscopy
33 Listeners
Gastroenterology Learning Network
10 Listeners
Gastroenterology & Endoscopy
3 Listeners